Andrea Pisesky | Congenital Heart Defects | Best Researcher Award

Published on 20/08/202620/08/2026 by Cardiology and Cardiovascular Medicine

Best Researcher Award

Andrea Pisesky
Stollery Children’s Hospital

Andrea Pisesky
Affiliation	Stollery Children’s Hospital
Country	Canada
Scopus ID	57219721692
Documents	9
Citations	478
h-index	7
Subject Area	Congenital Heart Defects
Event	Cardiology and Cardiovascular Medicine
ORCID	0000-0003-0094-0193

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada, with a documented research profile associated with congenital heart defects and cardiovascular medicine. The supplied bibliometric information records nine documents, 478 citations, and an h-index of 7. The profile also includes ORCID identifier 0000-0003-0094-0193, supporting persistent researcher identification. [1] [2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Andrea Pisesky is a researcher affiliated with Stollery Children’s Hospital in Canada whose documented scholarly profile focuses on congenital heart defects and cardiovascular medicine. The supplied bibliometric record identifies nine documents, 478 citations, and an h-index of 7 under Scopus author identifier 57219721692. These indicators provide a quantitative representation of documented research activity and citation visibility. The profile is additionally associated with ORCID identifier 0000-0003-0094-0193, supporting researcher identification and record disambiguation. This article presents the available academic information in a structured recognition profile, covering research orientation, contributions, publications, citation impact, and relevance to consideration for a Best Researcher Award within cardiovascular medicine.

Keywords

Andrea Pisesky, Best Researcher Award, congenital heart defects, cardiology, cardiovascular medicine, Stollery Children’s Hospital, Canada, Scopus, ORCID, research impact. [1] [2]

Introduction

Congenital heart defects are an important area of cardiovascular research because structural abnormalities of the heart and major vessels can require continuing clinical assessment and multidisciplinary management. Research in this field encompasses diagnosis, intervention, outcomes, epidemiology, and long-term care. Bibliographic databases such as Scopus provide standardized indicators that can assist in describing documented scholarly activity and citation performance. [1] [5]

Research Profile

The supplied profile places Andrea Pisesky within the research area of congenital heart defects and cardiovascular medicine, with an institutional affiliation at Stollery Children’s Hospital in Canada. The reported Scopus record contains nine documents, 478 citations, and an h-index of 7. ORCID identifier 0000-0003-0094-0193 provides an additional persistent identifier for researcher disambiguation. [1] [2]

Research Contributions

The documented subject focus is relevant to congenital cardiac conditions and cardiovascular medicine, disciplines that rely on clinical investigation, patient characterization, treatment evaluation, outcomes research, and interdisciplinary collaboration. Based on the supplied information, the research profile can be described within this broad domain without attributing specific scientific findings that are not independently established by the available publication record. [3]

Publications

The supplied Scopus information records nine documents associated with author identifier 57219721692. These documents constitute the reported scholarly output underlying the stated citation count and h-index. Publication-level details such as article titles, journals, dates, authorship, and DOI identifiers should be verified against the relevant bibliographic records before being used for detailed assessment. [1]

Research Impact

The reported bibliometric profile contains 478 citations and an h-index of 7. These measures provide quantitative indicators of citation activity associated with the supplied author record. Citation counts are dynamic and may change as databases are updated; consequently, bibliometric indicators should be considered alongside publication quality, research relevance, methodological contribution, and broader academic or clinical influence. [1]

Award Suitability

The available academic indicators provide relevant evidence for consideration within a researcher recognition framework focused on cardiology and cardiovascular medicine. The combination of documented scholarly output, citation activity, subject-area relevance, institutional affiliation, and persistent researcher identification can support an evidence-based nomination. Final eligibility and recognition should be determined according to the official criteria and review procedures of the organizing body. [4]

Conclusion

Andrea Pisesky’s supplied academic profile reflects research activity associated with congenital heart defects and cardiovascular medicine in Canada. The reported Scopus indicators of nine documents, 478 citations, and an h-index of 7 provide measurable evidence of documented scholarly visibility. Together with ORCID identification and institutional affiliation, these indicators form a structured basis for an academic recognition profile while remaining subject to independent verification and formal award evaluation.

External Links

References

Elsevier. (n.d.). Scopus author details: Andrea Pisesky, Author ID 57219721692. Scopus.
https://www.scopus.com/pages/authors/57219721692
ORCID. (n.d.). ORCID record: Andrea Pisesky. ORCID.
https://orcid.org/0000-0003-0094-0193
Journal article(2021.). Adverse fibrosis remodeling and aortopulmonary collateral flow are associated with poor Fontan outcomes.
https://doi.org/10.1186/s12968-021-00782-9
Journal article(2021.). Cardiology and Cardiovascular Medicine. Standardisation of management after Norwood operation has not improved 1-year outcomes.
https://doi.org/10.1017/S1047951120003376
Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
https://cardiology-conferences.pencis.com/

Emilia D’Elia | Heart Failure | Best Researcher Award

Published on 20/08/202621/08/2026 by Cardiology and Cardiovascular Medicine

Best Researcher Award

Emilia D’Elia
ASST Papa Giovanni XXIII, Italy

Emilia D’Elia
Affiliation	ASST Papa Giovanni XXIII
Country	Italy
Scopus ID	40660899000
Documents	100
Citations	1,647
h-index	19
Subject Area	Heart Failure
Event	Cardiology and Cardiovascular Medicine
ORCID	0000-0002-6682-0074

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a research profile focused on heart failure. The supplied bibliometric record reports 100 documents, 1,647 citations, and an h-index of 19, providing measurable indicators of scholarly productivity and visibility within cardiovascular medicine.[1]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Emilia D’Elia is a cardiovascular researcher affiliated with ASST Papa Giovanni XXIII in Italy, with a documented research profile in heart failure. Available bibliometric information identifies 100 documents, 1,647 citations, and an h-index of 19, indicating sustained publication activity and measurable academic visibility. Her subject specialization places her work within contemporary cardiovascular medicine, where heart failure research addresses diagnosis, treatment, outcomes, and disease management. The profile provides a quantitative basis for considering research recognition while acknowledging that bibliometric indicators should be interpreted alongside publication quality, originality, clinical relevance, collaboration, and broader contributions to cardiovascular science and patient care.[1]

Keywords

Emilia D’Elia; heart failure; cardiology; cardiovascular medicine; clinical research; scholarly impact; bibliometrics; citations; h-index; cardiovascular outcomes; ASST Papa Giovanni XXIII; Italy; research recognition; Best Researcher Award.

Introduction

Heart failure is a major area of cardiovascular research requiring evidence across prevention, diagnosis, pharmacological management, device therapy, and long-term outcomes. Contemporary clinical guidance emphasizes multidisciplinary and evidence-based approaches to improving outcomes for affected patients.[2] Researchers specializing in heart failure contribute to the development and evaluation of clinically relevant evidence.

Research Profile

The supplied profile identifies Emilia D’Elia with ASST Papa Giovanni XXIII in Italy and associates her principal subject area with heart failure. Her Scopus author identifier is 40660899000, while the reported record comprises 100 documents, 1,647 citations, and an h-index of 19. These indicators describe a research profile with established bibliometric visibility.[1]

Research Contributions

The available information supports characterization of D’Elia’s research within heart failure and cardiovascular medicine. Research in this field can contribute to understanding disease mechanisms, improving risk assessment, evaluating therapeutic strategies, and strengthening evidence-based clinical care. The documented publication and citation record provides measurable evidence of sustained engagement with the scientific literature.[1]

Publications

The supplied Scopus information reports 100 documents associated with the researcher profile. Because individual publication titles, journals, publication years, and article-level identifiers were not provided, this article does not assign specific publications or DOIs without verification. The complete bibliographic record can be reviewed through the linked Scopus author profile.[1]

Research Impact

The reported 1,647 citations and h-index of 19 provide quantitative measures of scholarly influence within the indexed research record. Citation metrics can assist in evaluating research visibility, although they do not independently establish methodological quality, originality, clinical effectiveness, or societal benefit. A balanced assessment should therefore consider both bibliometric and qualitative evidence.[1]

Award Suitability

Based on the supplied information, Emilia D’Elia presents characteristics relevant to consideration for a Best Researcher Award in cardiology and cardiovascular medicine, particularly through her documented activity in heart failure research and established bibliometric record. Final award assessment should additionally consider originality, publication quality, research leadership, clinical relevance, collaboration, and independently verifiable achievements.

Conclusion

Emilia D’Elia’s supplied academic profile reflects sustained research activity in heart failure and cardiovascular medicine, supported by 100 reported documents, 1,647 citations, and an h-index of 19. These indicators provide a quantitative foundation for academic recognition, while a complete award evaluation should incorporate verified publication quality, scientific originality, clinical significance, and broader research contributions.[1]

External Links

References

Elsevier. (n.d.). Scopus author details: Emilia D’Elia, Author ID 40660899000. Scopus.
https://www.scopus.com/pages/authors/40660899000
Journal article (2025.). SGLT2 inhibitors and new frontiers in heart failure treatment regardless of ejection fraction and setting.
https://doi.org/10.1093/eurheartjsupp/suae117
Journal article. (2026.). Sex-related disparities in elderly patients with heart failure with mildly reduced or preserved ejection fraction.
https://doi.org/10.1093/eschf/xvaf022
Cardiology and Cardiovascular Medicine. (2026.). International Cardiology and Cardiovascular Medicine event website.
https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on 11/08/202611/08/2026 by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt

Radwa Mehanna
Affiliation	Alexandria University
Country	Egypt
Scopus ID	55851530300
Documents	43
Citations	927
h-index	19
Subject Area	Cardiovascular Researches
Event	International Research Awards on Cardiology & Cardiovascular Medicine
ORCID	0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

External Links

References

Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
https://esev-eg.org/board/
Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
https://doi.org/10.4252/wjsc.v14.i1.1
Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
https://doi.org/10.1186/s40659-025-00593-7
Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
https://doi.org/10.1093/eurheartj/suab069.019
Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
https://doi.org/10.1016/j.vph.2023.107223

Zhi-Hui Zhu | Cardiovascular Researches | Innovative Research Award

Published on 23/06/2026 by Cardiology and Cardiovascular Medicine

Innovative Research Award

Zhi-Hui Zhu
Zhejiang University, China

Zhi-Hui Zhu
Affiliation	Zhejiang University
Country	China
Scopus ID	57199280440
Documents	4
Citations	73
h-index	3
Subject Area	Cardiovascular Researches
Event	International Research Awards on Cardiology & Cardiovascular Medicine

The Innovative Research Award recognizes scholarly achievements that have contributed to the advancement of biomedical and life science research. Zhi-Hui Zhu of Zhejiang University has developed a research profile characterized by investigations into liver development, regenerative biology, molecular genetics, and experimental disease modeling. Through studies employing zebrafish and mammalian systems, Zhu has contributed to understanding developmental regulation, tissue regeneration, and cellular lineage mechanisms relevant to human health and disease.[1] The body of work demonstrates interdisciplinary integration of genetics, developmental biology, and translational biomedical research, providing a foundation for future applications in regenerative medicine and cardiovascular-related biological investigations.[2]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

This article summarizes the scientific contributions of Zhi-Hui Zhu in developmental biology and regenerative research. The documented publications explore liver organogenesis, gene regulation, tissue regeneration, and transgenic model development. Collectively, these studies have contributed to understanding molecular pathways that govern organ formation and repair, providing insights applicable to broader biomedical and cardiovascular research contexts.[3]

Keywords

Developmental biology; Regenerative medicine; Zebrafish genetics; Liver development; Molecular signaling; Tissue regeneration; Functional genomics; Biomedical research.

Introduction

Modern biomedical research increasingly relies on model organisms to uncover mechanisms underlying organ development and disease progression. Zhu’s investigations have focused on genetic and cellular pathways involved in liver biology, utilizing zebrafish and mammalian systems to evaluate developmental processes and regenerative responses. These studies provide mechanistic evidence supporting the role of specific genes and signaling networks in maintaining tissue integrity and recovery following injury.[1][3]

Research Profile

Affiliated with Zhejiang University, Zhi-Hui Zhu has authored and co-authored peer-reviewed publications indexed in major scientific databases. The available metrics indicate four indexed documents, seventy-three citations, and an h-index of three. Research themes encompass developmental genetics, liver biology, transgenic technologies, and regenerative mechanisms, reflecting a consistent commitment to experimentally driven biological inquiry.[1]

Research Contributions

Among Zhu’s notable contributions is the characterization of liver-enriched gene family members essential for normal liver development in zebrafish, expanding knowledge of organogenesis and developmental regulation.[2] Additional investigations examined expression patterns of homologous genes in mammalian systems, providing comparative biological insights.[3] Research on Def haploinsufficiency demonstrated activation of p53-dependent TGFβ signaling during regenerative responses, revealing mechanisms associated with scar formation following partial hepatectomy.[4] Zhu also contributed to transgenic zebrafish methodologies supporting functional genomic analysis of candidate genes involved in tumor pathogenesis.[5]

Publications

Chang CQ et al. (2011). Liver-enriched gene 1a and 1b encode novel secretory proteins essential for normal liver development in zebrafish.
Zhu ZH et al. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse.
Zhu ZH et al. (2014). Haploinsufficiency of Def activates p53-dependent TGFβ signalling and causes scar formation after partial hepatectomy.
Ung CY et al. (2015). Mosaic zebrafish transgenesis for functional genomic analysis of cooperative genes in tumor pathogenesis.
Gao C et al. (2018). Hepatocytes in a normal adult liver are derived solely from embryonic hepatocytes.

Research Impact

The research portfolio has contributed valuable evidence regarding developmental pathways, tissue regeneration, and cellular lineage tracing. These findings support broader scientific efforts aimed at understanding disease mechanisms and regenerative therapies. The citation record further indicates continued scholarly engagement with the published findings, particularly in developmental and translational biology disciplines.[1][6]

Award Suitability

Zhu’s record demonstrates sustained contributions to biological research through original investigations, methodological development, and collaborative scientific output. The integration of developmental genetics and regenerative biology aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine, particularly where fundamental biological discoveries inform future therapeutic and translational applications.[5]

Conclusion

Zhi-Hui Zhu’s scholarly contributions reflect a focused research trajectory in developmental and regenerative biology. Through investigations involving gene regulation, organ development, and cellular regeneration, the researcher has advanced scientific understanding of biological processes relevant to health and disease. The documented body of work provides a credible basis for recognition through an academic research award program.[1]

External Links

References

Elsevier. (n.d.). Scopus author details: Zhi-Hui Zhu, Author ID 57199280440. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57199280440
Chang CQ, Hu MJ, Zhu ZH, et al. (2011). Liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish. PLoS ONE.
https://doi.org/10.1371/journal.pone.0022910
Zhu ZH, Hu MJ, Chang CQ, Peng JR. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse. Hereditas.
Zhu ZH, Chen J, Xiong JW, Peng JR. (2014). Haploinsufficiency of Def Activates p53-Dependent TGFβ Signalling and Causes Scar Formation after Partial Hepatectomy. PLoS ONE.
https://doi.org/10.1371/journal.pone.0096576
Ung CY, Guo F, Zhang X, Zhu Z, Zhu S. (2015). Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis. Journal of Visualized Experiments.
https://doi.org/10.3791/52567
Gao C, Zhu Z, Gao Y, et al. (2018). Hepatocytes in a Normal Adult Liver Are Derived Solely from the Embryonic Hepatocytes. Journal of Genetics and Genomics.
https://doi.org/10.1016/j.jgg.2017.12.003

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Published on 19/06/202619/06/2026 by Cardiology and Cardiovascular Medicine

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation	Università della Campania Vanvitelli
Country	Italy
Scopus ID	57194323816
Documents	119
Citations	3,964
h-index	33
Subject Area	Cardiovascular Researches
Event	International Research Awards on Cardiology & Cardiovascular Medicine
ORCID	0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Contents

Abstract
Keywords
Introduction
Research Profile
Research Contributions
Publications
Research Impact
Award Suitability
Conclusion
External Links
References

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
Evaluation of exercise interventions and their effects on cardiometabolic health.
Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

External Links

References

Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
https://www.scopus.com/authid/detail.uri?authorId=57194323816
Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
DOI: https://doi.org/10.3390/life16040657
Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
DOI: https://doi.org/10.3390/ijms26188980
Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
DOI: https://doi.org/10.3390/biomedicines13081817
Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
DOI: https://doi.org/10.3390/biomedicines13020273

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Published on 05/10/202405/10/2024 by Cardiology and Cardiovascular Medicine

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.

Prof. Jeanette Woolard | Hypertension | Best Researcher Award

Published on 03/01/202403/01/2024 by Cardiology and Cardiovascular Medicine

Prof. Jeanette Woolard | Hypertension | Best Researcher Award

University of Nottingham, United Kingdom

Prof. Jeanette Woolard, based at the University of Nottingham in the UK, is a distinguished expert in the field of Hypertension. With a notable academic career, Prof. Woolard has made significant contributions to hypertension research, advancing our understanding of cardiovascular health. Her work extends to both scholarly pursuits and practical applications in the field. As a respected figure in hypertension studies, Prof. Woolard continues to shape the landscape of cardiovascular research through her expertise, dedication, and commitment to improving health outcomes related to hypertension. Her influence extends beyond academia, positively impacting the broader medical community.

Professional Profile

Scopus

Education

Prof. Jeanette Woolard, is a distinguished scholar with a robust academic background. She earned her Ph.D. in Pharmacology and Physiology from the University of Nottingham, UK (1999-2002), showcasing her dedication to advancing medical knowledge. 🎓 Prior to this, she pursued an MSc in Cardiovascular Pharmacology at Queen’s University, Canada (1997-1999), honing her expertise in cardiovascular health. 🍁 Her academic journey began with a stellar BSc (Hons) in Life Sciences (Class I) at Queen’s University, Canada (1993-1997), setting the stage for a prolific career. Dr. [Name]’s academic milestones underscore her commitment to excellence in pharmacology and physiology. ✨

Honours and Awards

Prof. Jeanette Woolard, a trailblazing figure, has garnered significant recognition for her contributions to pharmacology and academia. In 2022, she received the prestigious Equity, Diversity, and Inclusion Prize from the British Pharmacological Society, sponsored by AstraZeneca, highlighting her commitment to promoting a diverse and inclusive scientific community. 🌐 Her accomplishments led to a Fellowship with the British Pharmacological Society in 2020, and she was honored with the University of Nottingham’s Vice Chancellor’s Award in the same year, acknowledging her outstanding contribution to Team Science. 🏆 Prof. Woolard’s dedication to teaching was recognized with the 2019 Staff Oscar Teaching Award for being the best dissertation supervisor. 🎓 Additionally, her influential work earned her the Bill Bowman Prize Lectureship in 2018, one of the British Pharmacological Society’s prestigious awards based on published work and a compelling lecture synopsis. 🏅

Patents

Prof. Jeanette Woolard’s impactful contributions extend to groundbreaking research in the field of cardiac and cardiovascular disease. In collaboration with a team, she co-authored a significant patent titled “Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease” at the University of Nottingham, UK. 🌐 The patent, documented under US20140094493 A1 (2014), WO2012104659A1 (2012), and EP2670734A1 (2013), underscores her commitment to advancing treatments in cardiovascular health. 🩺 This innovative work not only reflects her expertise in the domain but also positions Prof. Woolard as a key figure in the quest for novel therapeutic approaches to address cardiac and cardiovascular challenges. 🏅